​

Funding Round

Venture Round - Sangon Biotech

Venture Round - Sangon Biotech

Investment Firm

Overview

Sangon Biotech is engaged in the research and development of chemical synthesis of DNA.

Announced Date

Apr 19, 2023

Funding Type

Series Unknown

Highlights

Location

Asia

Social

Investor Lead

GL Capital

GL Capital

GL Capital is a early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

5

Investor Name
Participant InvestorGreenwoods Investment
Participant InvestorCPE
Participant InvestorGL Capital
Participant InvestorHuagai Capital
Participant InvestorNovo Holdings

Round Details and Background

Sangon Biotech raised $290440162 on 2023-04-19 in Venture Round

Sangon Biotech is engaged in the research and development of chemical synthesis of DNA.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 19, 2023
Venture Round - Sangon Biotech
8-290.4M
Jul 01, 2010
Series A - Sangon Biotech
1-6.2M

Recent Activity

There is no recent news or activity for this profile.